drugset / Trial / NCT02766855

Efficacy of Topical Cysteamine in Nephropathic Cyctinosis

NCT02766855 ↗

NaSingle-groupOpen-labelTreatment

Summary

The aim of this study is to evaluate the efficacy of topical cysteamine eye drops in the treatment of corneal cystine crystals deposits in patients with nephropathic cystinosis.

Timeline

Start
2004-01
Primary completion
2012-12
Completion
2016-03

Outcome

Missed primary endpoint

paper Improvement of photophobia was not clinically significant in symptomatic patients. PMID 28057644 ↗

paper Patients displayed statistically significant worsening of corneal cystine deposits during the follow-up period. PMID 28057644 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Cysteamine Unknown 0.55 % Topical